Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling. Ganzel C, Sun Z, Baslan T, Zhang Y, et al. Leuk Res 2022;123:106971.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ganzel C, Sun Z, Baslan T, Zhang Y, et al. Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling. Leuk Res 2022;123:106971.
PMID: 36332294